David P. Southwell - Insider Trading & Ownership

Location
C/O Inotek Pharmaceuticals Corporation, 91 Hartwell Avenue, Lexington, MA
Summary
The estimated net worth of David P. Southwell is at least $3.21M dollars as of September 11, 2025. David P. Southwell is the Director of PTC THERAPEUTICS, INC. and owns shares of PTC THERAPEUTICS, INC. (PTCT) stock worth about $1.22M. David P. Southwell is the Director of ROCKET PHARMACEUTICALS, INC. and owns shares of ROCKET PHARMACEUTICALS, INC. (RCKT) stock worth about $1.14M. David P. Southwell is the Chief Executive Officer, Director of TScan Therapeutics, Inc. and owns shares of TScan Therapeutics, Inc. (TCRX) stock worth about $852K.
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of David P. Southwell

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PTCT PTC THERAPEUTICS, INC. Director $1.22M -$700K -36.4% Sep 9, 2025
RCKT, RCKTW ROCKET PHARMACEUTICALS, INC. Director $1.14M Jun 18, 2025
TCRX TScan Therapeutics, Inc. Chief Executive Officer, Director $852K Feb 2, 2023

Insider Transactions Reported by David P. Southwell:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.